{"PubmedBookArticle": [], "PubmedArticle": [{"MedlineCitation": {"OtherAbstract": [], "CitationSubset": ["IM"], "OtherID": [], "GeneralNote": [], "SpaceFlightMission": [], "KeywordList": [], "InvestigatorList": [], "PMID": "8741601", "DateCompleted": {"Year": "1996", "Month": "11", "Day": "29"}, "DateRevised": {"Year": "2019", "Month": "05", "Day": "16"}, "Article": {"Language": ["eng"], "ArticleDate": [], "ELocationID": [], "Journal": {"ISSN": "0916-7250", "JournalIssue": {"Volume": "58", "Issue": "5", "PubDate": {"Year": "1996", "Month": "May"}}, "Title": "The Journal of veterinary medical science", "ISOAbbreviation": "J Vet Med Sci"}, "ArticleTitle": "Effect of M-711 on experimental skin reactions induced by chemical mediators in rats.", "Pagination": {"StartPage": "419", "EndPage": "423", "MedlinePgn": "419-23"}, "Abstract": {"AbstractText": ["We investigated the mechanism of anti-allergic action of Moku-boi-to (M-711) and effects on the skin reactions induced by chemical mediators as the model of allergic dermatitis. More than 20 mg/kg BW of M-711 significantly suppressed the enhancement of capillary permeability induced by histamine, LTC4, and anti-serum in the rat skin. Anti-histaminic effect of 40 mg/kg BW of M-711 was equipotent to same as the optimal doses of azelastine and diphenhydramine, respectively. As to anti-LTC4 action, 20 mg of M-711 was compared to the optimal dose of diphenhydramine. Those data showed that M-711 has the suppressive effects on the chemical mediators such as histamine and LTC4 and reduced the skin reaction induced by antigen-antibody response."]}, "AuthorList": [{"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Laboratory Animal Science, Nippon Medical School, Tokyo, Japan."}], "LastName": "Shichinohe", "ForeName": "K", "Initials": "K"}, {"Identifier": [], "AffiliationInfo": [], "LastName": "Shimizu", "ForeName": "M", "Initials": "M"}, {"Identifier": [], "AffiliationInfo": [], "LastName": "Kurokawa", "ForeName": "K", "Initials": "K"}], "PublicationTypeList": ["Journal Article"]}, "MedlineJournalInfo": {"Country": "Japan", "MedlineTA": "J Vet Med Sci", "NlmUniqueID": "9105360", "ISSNLinking": "0916-7250"}, "ChemicalList": [{"RegistryNumber": "0", "NameOfSubstance": "Anti-Allergic Agents"}, {"RegistryNumber": "0", "NameOfSubstance": "Drugs, Chinese Herbal"}, {"RegistryNumber": "0", "NameOfSubstance": "Phthalazines"}, {"RegistryNumber": "0", "NameOfSubstance": "moku-boi-to"}, {"RegistryNumber": "2CU6TT9V48", "NameOfSubstance": "Leukotriene C4"}, {"RegistryNumber": "7S5I7G3JQL", "NameOfSubstance": "Dexamethasone"}, {"RegistryNumber": "8GTS82S83M", "NameOfSubstance": "Diphenhydramine"}, {"RegistryNumber": "ZQI909440X", "NameOfSubstance": "azelastine"}], "MeshHeadingList": [{"QualifierName": [], "DescriptorName": "Animals"}, {"QualifierName": ["therapeutic use"], "DescriptorName": "Anti-Allergic Agents"}, {"QualifierName": ["drug therapy"], "DescriptorName": "Dermatitis, Allergic Contact"}, {"QualifierName": ["therapeutic use"], "DescriptorName": "Dexamethasone"}, {"QualifierName": ["therapeutic use"], "DescriptorName": "Diphenhydramine"}, {"QualifierName": ["therapeutic use"], "DescriptorName": "Drugs, Chinese Herbal"}, {"QualifierName": ["toxicity"], "DescriptorName": "Leukotriene C4"}, {"QualifierName": [], "DescriptorName": "Male"}, {"QualifierName": ["therapeutic use"], "DescriptorName": "Phthalazines"}, {"QualifierName": [], "DescriptorName": "Phytotherapy"}, {"QualifierName": [], "DescriptorName": "Plants, Medicinal"}, {"QualifierName": [], "DescriptorName": "Rats"}, {"QualifierName": [], "DescriptorName": "Rats, Sprague-Dawley"}, {"QualifierName": [], "DescriptorName": "Skin Tests"}]}, "PubmedData": {"ReferenceList": [], "History": [{"Year": "1996", "Month": "5", "Day": "1"}, {"Year": "1996", "Month": "5", "Day": "1", "Hour": "0", "Minute": "1"}, {"Year": "1996", "Month": "5", "Day": "1", "Hour": "0", "Minute": "0"}], "PublicationStatus": "ppublish", "ArticleIdList": ["8741601", "10.1292/jvms.58.419"]}}]}